Voisard Asset Management Group, Inc. Bluebird Bio, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $205 Billion
- Q2 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 1,000 shares of BLUE stock, worth $570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$570
Previous $1.28 Million
23.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
162Shares Held
80MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$8.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$5.87 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$3.64 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.93 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$2.66 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $44M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...